How to Navigate the Challenges of Commercialization
Learning the Ropes - Irving Institute’s Translational Therapeutics Accelerator (TRx) Helps Researchers Navigate the Challenges of Commercialization
For researchers who are more accustomed to the laboratory than the boardroom, the notion of trying to commercialize a discovery can feel overwhelming. Translating complex science and years of research into a viable “pitch” is an intimidating challenge by itself. And the prospect of making the necessary connections with tech and venture capitalist (VC) groups can feel impossible. But perhaps the most difficult part of the process is simply knowing where to start.
Thanks to resources like the Irving Institute’s Translational Therapeutics Accelerator (TRx), researchers at Columbia University Irving Medical Center (CUIMC) don’t have to go it alone. One of a number of accelerator programs available in partnership with Columbia Technology Ventures (CTV), the TRx is designed to both streamline the commercialization process and help researchers understand what they need to successfully move their research toward the market.
The TRx offers help with every step of the commercialization process and lets researchers leverage the considerable resources available through CTV.